Abstract
Estrogen can effectively prevent estrogen deficiency-induced bone loss in animals and humans. However, its mechanism remains unknown. Osteoblast-derived Matrix metalloproteinse-1 (MMP-1), MMP-2, and tissue inhibitor of metalloproteinase-1 (TIMP-1) recently were implicated as playing important roles in initiating bone resorption. Therefore, we tested the effects of 17β-estradiol (E2) on MMP-1, MMP-2, and TIMP-1 production in cultures of human osteoblastic MG-63 cells and normal human osteoblasts (hOB). MMP-1, MMP-2 and TIMP-1 concentrations in the culture medium were determined by ELISA, and activity of MMP-2 was assessed by ELISA. After 12–48 h of treatment, E2 at 10−8M decreased MMP-1 level in cultures of MG-63 cells or hOB. Treatment with increasing dose of E2 in MG-63 cells or hOB caused a dose-dependent decrease in MMP-1 synthesis. E2 had no influence on MMP-2 and TIMP-1 production in MG-63 cells or hOB cultures, as well as activation of latent MMP-2. In conclusion, E2 represses MMP-1 synthesis, and this effect may contribute to its action on the inhibition of bone resorption, followed by prevention of bone loss. Increasing MMP-1 production followed by estrogen deficiency may contribute to the mechanisms involved in postmenopausal osteoporosis.
Similar content being viewed by others
References
Turner, R. T., Riggs, B. I., and Spelsberg, T. C. (1994). Endocr. Rev. 16, 275–300.
Rifas, L., Fausto, A., Scott, M. J., Avioli, L. V., and Welgus, H. G. (1994). Endocrinology 134, 213–221.
Meikle, M. C., Bord, S., Hembry, R. M., Compston, J., Croucher, P. I., and Reynold, J. J. (1992). J. Cell. Sci. 103, 1093–1099.
Rifas, L., Halstead, L. R., Peck, H. W., Avioli, L. V., and Welgus, H. G. (1989). J. Clin. Invest. 84, 686–694.
Westermarck, J. and Kahari, V. (1999). FASEB J. 13, 781–792.
Breckon, J. J. W., Papaioannou, S., Kon, L. W. M., Tumber, A., Hembry, R. M., Murphy, G., Reynolds, J. J., and Meikle, M. C. (1999). J. Bone Miner Res. 14, 1880–1890.
Aimes, R. T. and Quigley, J. P. (1995). J. Biol. Chem. 270, 5872–5876.
Robey, P. G. and Termine, J. D. (1985). Calcified Tissue Int. 37, 53.
Rodan, G. A. and Martin, T. J. (1981). Calcif. Tissue Int. 33, 349–351.
Chambers, T. J., Darby, J. A., and Fuller, K. (1985). Cell Tissue Res. 241, 671–675.
Partridge, N. C., Jeffrey, J. J., Ehlich, L. S., Teitelbaum, S. L., Fliszar, C., Welgus, H. G., and Kahn, A. J. (1987). Endocrinology 120, 1956–1962.
Sakamoto, S. and Sakamoto, M. (1984). Biomed. Res. 5, 39–46.
Sakamoto, S. and Sakamoto, M. (1984). Biochem. Int. 9, 51–58.
Holliday, L. S., Welgus, H. G., Fliszar, C. L., Veith, G. M., Jeffrey, J. J., and Gluck, S. L. (1997). J. Biol. Chem. 272, 22,053–22,058.
Varghese, S., Delany, A. M., Liang, L., Gabbitas, B., Jeffrey, J. J., and Canalis, E. (1996). Endocrinology 137, 431–437.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liao, Ey., Luo, Xh. Effects of 17β-estradiol on the expression of matrix metalloproteinase-1, -2 and tissue inhibitor of metalloproteinase-1 in human osteoblast-like cell cultures. Endocr 15, 291–295 (2001). https://doi.org/10.1385/ENDO:15:3:291
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:15:3:291